Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction

Angiogenesis

Volumn 15, Issue 2, 2012, Pages 229-242

  Lee, Yoon Jin ^a   Lee, Hae Jun ^a   Choi, Seo Hyun ^a,b   Jin, Yeung Bae ^a   An, Ho Jung ^c   Kang, Jin Hyoung ^c   Yoon, Sam S ^d   Lee, Yun Sil ^e  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Korea University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e Ewha Womans University   (South Korea)

Author keywords

Angiogenic balance; Endothelial cell (EC); Heat shock protein 25 27 (HSPB1); Vascular endothelial growth (VEGF)

Indexed keywords

ADENOVIRUS VECTOR; HEAT SHOCK PROTEIN 27; VASCULOTROPIN; HEAT SHOCK PROTEIN; HSPB1 PROTEIN, HUMAN; HSPB1 PROTEIN, MOUSE; TUMOR PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER GROWTH; COLON CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HSPB1 GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SARCOMA; TUMOR CELL; WOUND HEALING; ANIMAL; COLON TUMOR; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ADENOVIRIDAE;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; ENDOTHELIAL CELLS; HEAT-SHOCK PROTEINS; HSP27 HEAT-SHOCK PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84865146919     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9255-3     Document Type: Article

References (42)

1. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9(6):669-676. doi:10.1038/nm0603-669 (Pubitemid 36749215)
2. Chung AS, Ferrara N (2010) Targeting the tumor microenvironment with SRC kinase inhibition. Clin Cancer Res 16(3):775-777. doi:10.1158/1078-0432.CCR-09- 3081
3. Ferrara N, Gerber HP (2001) The role of vascular endothelial growth factor in angiogenesis. Acta Haematol 106(4):148-156 (Pubitemid 34124153)
4. Folkman J (2003) Angiogenesis inhibitors: a new class of drugs. Cancer Biol Ther 2(4 Suppl 1):S127-133
5. Folkman J, Ryeom S (2005) Is oncogene addiction angiogenesisdependent? Cold Spring Harb Symp Quant Biol 70:389-397. doi: 10.1101/sqb.2005.70.042 (Pubitemid 44124894)
6. Evans IM, Britton G, Zachary IC (2008) Vascular endothelial growth factor induces heat shock protein (HSP) 27 serine 82 phosphorylation and endothelial tubulogenesis via protein kinase D and independent of p38 kinase. Cell Signal 20(7):1375-1384. doi:10.1016/j.cellsig.2008.03.002
7. Yancopoulos GD (2010) Clinical application of therapies targeting VEGF. Cell 143(1):13-16. doi:10.1016/j.cell.2010.09.028
8. Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS (2008) Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by upregulation of multiple proangiogenic factors. Clin Cancer Res 14(5):1529-1539. doi:10.1158/1078-0432.CCR-07-4126 (Pubitemid 351413938)
9. Richter K, Haslbeck M, Buchner J (2010) The heat shock response: life on the verge of death. Mol Cell 40(2):253-266. doi: 10.1016/j.molcel.2010.10.006
10. Ousman SS, Tomooka BH, van Noort JM, Wawrousek EF, O'Connor KC, Hafler DA, Sobel RA, Robinson WH, Steinman L (2007) Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature 448(7152):474-479. doi: 10.1038/nature05935 (Pubitemid 47123511)
11. Didelot C, Schmitt E, Brunet M, Maingret L, Parcellier A, Garrido C (2006) Heat shock proteins: endogenous modulators of apoptotic cell death. Mol Chaperones Health Dis 171-198
12. Kase S, He S, Sonoda S, Kitamura M, Spee C, Wawrousek E, Ryan SJ, Kannan R, Hinton DR (2010) AlphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood 115(16):3398-3406. doi:10.1182/blood-2009-01-197095
13. Dimberg A, Rylova S, Dieterich LC, Olsson AK, Schiller P, Wikner C, Bohman S, Botling J, Lukinius A, Wawrousek EF, Claesson-Welsh L (2008) AlphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood 111(4):2015-2023. doi:10.1182/blood-2007-04- 087841 (Pubitemid 351451512)
14. Liao WC, Wu MS, Wang HP, Tien YW, Lin JT (2009) Serum heat shock protein 27 is increased in chronic pancreatitis and pancreatic carcinoma. Pancreas 38(4):422-426. doi: 10.1097/MPA.0b013e318198281d
15. Huang Q, Ye J, Chen W, Wang L, Lin W, Lin J, Lin X (2010) Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma. Clin Chem Lab Med 48(2):263-269. doi:10.1515/CCLM.2010.043
16. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C (2007) Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol 81(1): 15-27. doi:10.1189/jlb.0306167 (Pubitemid 46021247)
17. Lee Y, Lee D, Cho C, Chung H, Bae S, Jhon G, Soh J, Jeoung D, Lee S, Lee Y (2005) HSP25 inhibits radiation-induced apoptosis through reduction of PKCδä-mediated ROS production. Oncogene 24(23):3715-3725 (Pubitemid 40826871)
18. Lee YJ, Lee DH, Cho CK, Bae S, Jhon GJ, Lee SJ, Soh JW, Lee YS (2005) HSP25 inhibits protein kinase C delta-mediated cell death through direct interaction. J Biol Chem 280(18):18108-18119. doi:10.1074/jbc.M501131200 (Pubitemid 41389056)
19. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 85(19): 1558-1570 (Pubitemid 23304684)
20. Geum D, Son GH, Kim K (2002) Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. J Biol Chem 277(22):19913-19921. doi:10.1074/jbc.M104396200 (Pubitemid 34967512)
21. Lee YJ, Koch M, Karl D, Torres-Collado AX, Fernando NT, Rothrock C, Kuruppu D, Ryeom S, Iruela-Arispe ML, Yoon SS (2010) Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1. Cancer Res 70(3):948-956. doi:10.1158/0008-5472.CAN-09-3094
22. DuPage M, Dooley AL, Jacks T (2009) Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat Protoc 4(7):1064-1072. doi:10.1038/nprot.2009.95
23. Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, Takeuchi O, Bronson RT, Crowley D, Korsmeyer SJ, Yoon SS, Hornicek FJ, Weissleder R, Jacks T (2007) A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med 13(8):992-997. doi:10.1038/nm1602 (Pubitemid 47222037)
24. Ryeom S, Baek KH, Rioth MJ, Lynch RC, Zaslavsky A, Birsner A, Yoon SS, McKeon F (2008) Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Cancer Cell 13(5):420-431. doi:10.1016/j.ccr.2008.02.018 (Pubitemid 351609439)
25. Montrucchio G, Lupia E, Battaglia E, Del Sorbo L, Boccellino M, Biancone L, Emanuelli G, Camussi G (2000) Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol 20(1):80-88 (Pubitemid 30048349)
26. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS (2005) Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 65(13): 5881-5889. doi:10.1158/0008-5472.CAN-04-4078 (Pubitemid 40911194)
27. Roeckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, Weich HA (1998) Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 241(1):161-170. doi:10.1006/excr.1998.4039 (Pubitemid 28366590)
28. Goldman CK, Kendall RL, Cabrera G, Soroceanu L, Heike Y, Gillespie GY, Siegal GP, Mao X, Bett AJ, Huckle WR, Thomas KA, Curiel DT (1998) Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA 95(15):8795-8800 (Pubitemid 28350568)
29. Krepuska M, Szeberin Z, Sotonyi P, Sarkadi H, Fehervari M, Apor A, Rimely E, Prohaszka Z, Acsady G (2010) Serum level of soluble Hsp70 is associated with vascular calcification. Cell Stress Chaperones. doi:10.1007/s12192-010-0237-3
30. Rayner K, Chen YX, McNulty M, Simard T, Zhao X, Wells DJ, de Belleroche J, O'Brien ER (2008) Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ Res 103(2):133-141. doi:10.1161/CIRCRESAHA.108.172155
31. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10(2):86-103 (Pubitemid 40942470)
32. Melle C, Ernst G, Escher N, Hartmann D, Schimmel B, Bleul A, Thieme H, Kaufmann R, Felix K, Friess HM, Settmacher U, Hommann M, Richter KK, Daffner W, Taubig H, Manger T, Claussen U, von Eggeling F (2007) Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem 53(4):629-635. doi:10.1373/clinchem.2006.079194 (Pubitemid 46580232)
33. Kim EH, Lee HJ, Lee DH, Bae S, Soh JW, Jeoung D, Kim J, Cho CK, Lee YJ, Lee YS (2007) Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. Cancer Res 67(13):6333-6341. doi: 10.1158/0008-5472.CAN-06-4344 (Pubitemid 47037516)
34. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182-1186
35. Jain RK (2001) Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 7(9):987-989. doi:10.1038/nm0901-987 (Pubitemid 32937367)
36. Wachsberger P, Burd R, Dicker AP (2003) Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin Cancer Res 9(6):1957-1971 (Pubitemid 36687614)
37. Dakappagari N, Neely L, Tangri S, Lundgren K, Hipolito L, Estrellado A, Burrows F, Zhang H (2010) An investigation into the potential use of serum Hsp70 as a novel tumour biomarker for Hsp90 inhibitors. Biomarkers 15(1):31-38. doi:10.3109/13547500903261347
38. Sreekumar PG, Kannan R, Kitamura M, Spee C, Barron E, Ryan SJ, Hinton DR (2010) AlphaB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells. PLoS One 5(10):e12578. doi:10.1371/journal.pone.0012578
39. Folkman J, Kalluri R (2004) Cancer without disease. Nature 427(6977):787. doi:10.1038/427787a (Pubitemid 38297724)
40. Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR Jr, Libutti SK (2000) Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer. Clin Cancer Res 6(12):4628-4634 (Pubitemid 32110397)
41. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88(2):277-285 (Pubitemid 28015876)
42. Zaslavsky A, Baek KH, Lynch RC, Short S, Grillo J, Folkman J, Italiano JE Jr, Ryeom S (2010) Platelet-derived thrombospondin-1 is a critical negative regulator and potential biomarker of angiogenesis. Blood 115(22):4605-4613. doi:10.1182/blood-2009-09-242065